Keith D. Robertson

18.0k total citations · 6 hit papers
130 papers, 13.5k citations indexed

About

Keith D. Robertson is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Keith D. Robertson has authored 130 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 24 papers in Genetics and 21 papers in Oncology. Recurrent topics in Keith D. Robertson's work include Epigenetics and DNA Methylation (90 papers), Cancer-related gene regulation (36 papers) and RNA modifications and cancer (29 papers). Keith D. Robertson is often cited by papers focused on Epigenetics and DNA Methylation (90 papers), Cancer-related gene regulation (36 papers) and RNA modifications and cancer (29 papers). Keith D. Robertson collaborates with scholars based in United States, China and South Korea. Keith D. Robertson's co-authors include Peter A. Jones, Alan P. Wolffe, Bilian Jin, Tomoki Yokochi, Qian Tao, Beth O. Van Emburgh, Richard F. Ambinder, Theresa M. Geiman, Slimane Ait‐Si‐Ali and Peter Lloyd Jones and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Keith D. Robertson

126 papers receiving 13.3k citations

Hit Papers

DNA methylation and human disease 1999 2026 2008 2017 2005 2000 2000 1999 2001 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DNA methylation and human disease
    2005 2.2k citations Keith D. Robertson profile →
  2. DNA methylation in health and disease
    2000 825 citations Keith D. Robertson et al. profile →
  3. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
    2000 737 citations Keith D. Robertson et al. profile →
  4. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors
    1999 683 citations Keith D. Robertson, Felicidad A. Gonzales et al. Nucleic Acids Research profile →
  5. DNA methylation, methyltransferases, and cancer
    2001 578 citations Keith D. Robertson profile →
  6. DNA Methylation: Superior or Subordinate in the Epigenetic Hierarchy?
    2011 556 citations Bilian Jin, Keith D. Robertson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith D. Robertson United States 56 10.8k 2.2k 1.9k 1.7k 817 130 13.5k
Martin Widschwendter United Kingdom 55 7.6k 0.7× 1.8k 0.8× 2.1k 1.2× 2.5k 1.5× 605 0.7× 184 10.4k
Gangning Liang United States 61 14.4k 1.3× 2.2k 1.0× 1.4k 0.8× 3.5k 2.0× 558 0.7× 162 16.9k
Lucia Altucci Italy 62 9.9k 0.9× 1.7k 0.8× 2.1k 1.2× 1.5k 0.9× 1.0k 1.3× 321 14.5k
Saadi Khochbin France 73 14.0k 1.3× 1.9k 0.9× 2.7k 1.4× 1.2k 0.7× 952 1.2× 203 16.5k
James Davie Canada 59 13.8k 1.3× 2.7k 1.3× 1.8k 1.0× 1.3k 0.8× 520 0.6× 252 16.6k
Jacques Côté Canada 68 14.4k 1.3× 1.3k 0.6× 1.5k 0.8× 1.2k 0.7× 463 0.6× 163 16.3k
Benjamin A. García United States 78 16.0k 1.5× 1.5k 0.7× 1.8k 1.0× 2.1k 1.2× 1.2k 1.4× 333 20.3k
Susan J. Clark Australia 65 11.2k 1.0× 2.1k 1.0× 1.1k 0.6× 3.4k 2.0× 353 0.4× 202 14.5k
Ali Shilatifard United States 92 26.0k 2.4× 2.5k 1.2× 2.0k 1.1× 2.2k 1.3× 792 1.0× 257 29.4k
Melanie Ehrlich United States 52 10.3k 1.0× 2.4k 1.1× 907 0.5× 1.6k 0.9× 435 0.5× 176 12.2k

Countries citing papers authored by Keith D. Robertson

Since Specialization
Citations

This map shows the geographic impact of Keith D. Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith D. Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith D. Robertson more than expected).

Fields of papers citing papers by Keith D. Robertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith D. Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith D. Robertson. The network helps show where Keith D. Robertson may publish in the future.

Co-authorship network of co-authors of Keith D. Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Keith D. Robertson. A scholar is included among the top collaborators of Keith D. Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith D. Robertson. Keith D. Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Ryan T., Ryan A. Hlady, Xiaoyu Pan, et al.. (2025). SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation. Genome biology. 26(1). 22–22. 2 indexed citations
2.
Conteduca, Giuseppina, Davide Cangelosi, Chiara Baldo, et al.. (2024). Impact of NSD1 Alternative Transcripts in Actin Filament Formation and Cellular Division Pathways in Fibroblasts. Genes. 15(9). 1117–1117.
3.
Wagner, Ryan T., Ryan A. Hlady, Xiaoyu Pan, et al.. (2023). SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner. Molecular Oncology. 18(1). 44–61. 3 indexed citations
4.
Binder, Moritz, Ryan M. Carr, Terra L. Lasho, et al.. (2022). Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia. Nature Communications. 13(1). 1434–1434. 14 indexed citations
5.
Buckarma, EeeLN H., Jennifer A. Yonkus, Nathan W. Werneburg, et al.. (2022). SHP2 inhibition enhances Yes-associated protein–mediated liver regeneration in murine partial hepatectomy models. JCI Insight. 7(15). 12 indexed citations
6.
Hlady, Ryan A., Xia Zhao, Ju Dong Yang, et al.. (2019). Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA. Theranostics. 9(24). 7239–7250. 66 indexed citations
7.
Liu, Jingping, Erik P. Castle, Douglas F. Lake, et al.. (2018). Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation. Journal of Proteome Research. 18(1). 331–340. 37 indexed citations
8.
Zhao, Xiangxuan, William Puszyk, Zaiming Lu, et al.. (2014). Small Molecule Inhibitor YM155-Mediated Activation of Death Receptor 5 Is Crucial for Chemotherapy-Induced Apoptosis in Pancreatic Carcinoma. Molecular Cancer Therapeutics. 14(1). 80–89. 19 indexed citations
9.
Liu, Feiyan, Qianqian Liu, Dafeng Yang, et al.. (2011). Verticillin A Overcomes Apoptosis Resistance in Human Colon Carcinoma through DNA Methylation-Dependent Upregulation of BNIP3. Cancer Research. 71(21). 6807–6816. 50 indexed citations
10.
Pei, Lirong, Gyan Srivastava, Trupti Joshi, et al.. (2011). Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing. Nucleic Acids Research. 39(19). e127–e127. 49 indexed citations
11.
Jin, Bilian, Bing Yao, Jian‐Liang Li, et al.. (2009). DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer. Cancer Research. 69(18). 7412–7421. 90 indexed citations
12.
Gopalakrishnan, Suhasni, Beth O. Van Emburgh, Jixiu Shan, et al.. (2009). A Novel DNMT3B Splice Variant Expressed in Tumor and Pluripotent Cells Modulates Genomic DNA Methylation Patterns and Displays Altered DNA Binding. Molecular Cancer Research. 7(10). 1622–1634. 77 indexed citations
13.
Demircan, Berna, et al.. (2008). Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes and Cancer. 48(1). 83–97. 46 indexed citations
14.
Jung, Yeonjoo, Jinah Park, Tai Young Kim, et al.. (2007). Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. Journal of Molecular Medicine. 85(10). 1137–1148. 59 indexed citations
15.
Chan, Stephen L., Yan Cui, Andrew van Hasselt, et al.. (2007). The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Laboratory Investigation. 87(7). 644–650. 83 indexed citations
16.
Kim, Tae‐You, Sheng Zhong, C. Robert Fields, Jeong Hoon Kim, & Keith D. Robertson. (2006). Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant Glioma. Cancer Research. 66(15). 7490–7501. 141 indexed citations
17.
Zhao, Lisa, et al.. (2006). An EBF3-Mediated Transcriptional Program That Induces Cell Cycle Arrest and Apoptosis. Cancer Research. 66(19). 9445–9452. 49 indexed citations
18.
Ai, Lingbao, Tae‐You Kim, C. Robert Fields, et al.. (2006). Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer Progression. Cancer Research. 66(16). 7899–7909. 71 indexed citations
19.
Ai, Lingbao, Qian Tao, Sheng Zhong, et al.. (2006). Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 27(7). 1341–1348. 154 indexed citations
20.
Bender, Christina M., Mark L. Gonzalgo, Felicidad A. Gonzales, et al.. (1999). Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands. Molecular and Cellular Biology. 19(10). 6690–6698. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Widschwendter Breakdown of academic impact, for papers by Gangning Liang Breakdown of academic impact, for papers by Lucia Altucci Breakdown of academic impact, for papers by Saadi Khochbin Breakdown of academic impact, for papers by James Davie Breakdown of academic impact, for papers by Jacques Côté Breakdown of academic impact, for papers by Benjamin A. García Breakdown of academic impact, for papers by Susan J. Clark Breakdown of academic impact, for papers by Ali Shilatifard Breakdown of academic impact, for papers by Melanie Ehrlich
Rankless by CCL
2026